7 completed, 3 unknown, 2 not yet recruiting, 1 terminated. 14 Phase 2, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 7, Unknown 3, Not yet recruiting 2, Terminated 1, Withdrawn 1 |
| Phase 3 | 6 | Completed 4, Unknown 1, Withdrawn 1 |
Follow Fasciitis, Plantar: new trials by email Literature Review of Fasciitis, Plantar trials Research Report on Fasciitis, Plantar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double-Blinded Study on Rapid and Sustained Pain Relief Topical Cannabidiol for Plantar Fasciitis transdermal CBD cream (Tolcylen®, Marlinz Pharma), Matched Placebos - Plantar Fasciitis | Phase 2 | Not yet recruiting | University of Florida | 50 | 2026-09-01 | 2026-09-03 |
| Efficacy of Extracorporeal Shockwave Therapy on Plantar Fasciitis in Patients With Peripheral Neuropathy Extracorporeal shockwave therapy (ESWT) - Neuropathic Pain, Plantar Fasciitis | Phase 2 | Not yet recruiting | National Taiwan University Hospital | 114 | 2026-05-01 | 2026-05-14 |
| A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA) Collagenase Clostridium Histolyticum (CCH), Placebo - Plantar Fasciitis | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 231 | 2024-01-03 | 2025-09-30 |
| A Novel Approach to Plantar Fasciitis in the Aging Population minimal shoes and foot strengthening and flexibility exercises, Supportive Footwear, foot orthotic device and foot flexibility exercises - Plantar Fasciitis, Chronic | Phase 2 | Unknown | University of South Florida | 138 | 2023-08-07 | 2024-05-21 |
| The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis Botulinum Toxin A, Dexamethasone - Plantar Fasciitis | Phase 2 / Phase 3 | Completed | Western Institute for Veterans Research | 62 | 2022-08-23 | 2025-04-02 |
| Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain AbobotulinumtoxinA 300 UNT - Plantar Fasciitis, Plantar Fasciitis, Chronic | Phase 2 | Unknown | University Foot and Ankle Foundation | 30 | 2019-11-20 | 2020-09-24 |
| DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis DAXI 80 U, DAXI 120 U, Placebo - Plantar Fasciitis | Phase 2 | Completed | Revance Therapeutics, Inc. | 155 | 2018-12-31 | 2023-09-21 |
| Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis Botulinum Toxins, Type A, Placebo - Plantar Fasciitis | Phase 2 | Completed | Revance Therapeutics, Inc. | 59 | 2017-06-12 | 2023-09-18 |
| DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis daxibotulinumtoxin type A, Placebo - Plantar Fasciitis | Phase 2 | Terminated | Revance Therapeutics, Inc. | 7 | 2016-11-14 | 2024-04-03 |
| Micronized dHACM Injectable for the Treatment of Plantar Fasciitis AmnioFix® Injectable, Saline Injection - Fasciitis, Plantar | Phase 2 / Phase 3 | Completed | MiMedx Group, Inc. | 147 | 2015-03-31 | 2020-11-17 |
| Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis Corticosteroid injection (Bupivacaine and Depo Medrol), Platelet rich plasma injection - Plantar Fasciitis | Phase 2 / Phase 3 | Withdrawn | King Hamad University Hospital, Bahrain | 2013-06-01 | 2019-08-16 | |
| Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Extracorporeal shock wave therapy 1, Extracorporeal shock wave therapy 2 - Plantar Fasciitis | Phase 2 / Phase 3 | Unknown | Isfahan University of Medical Sciences | 48 | 2012-11-01 | 2013-02-07 |
| Exercise Versus Corticosteroid Randomized Clinical Trial for Plantar Fasciitis Karaoke Exercise, Balance walking exercise, Forefoot extension exercise - Fasciitis, Plantar | Phase 2 / Phase 3 | Completed | University of British Columbia | 56 | 2011-05-01 | 2013-03-22 |
| Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis Botulinum toxin type A, Placebo - Chronic Plantar Fasciitis | Phase 2 / Phase 3 | Completed | Ipsen | 40 | 2005-07-01 | 2019-11-22 |
Neuralgia (1) · Pain (1) · Peripheral Nervous System Diseases (1)
Fasciitis (14) · Foot Diseases (14) · Musculoskeletal Diseases (14) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Pain (1)
Botulinum Toxins, Type A (3) · Dexamethasone (2) · Adrenal Cortex Hormones (1) · Bupivacaine (1) · Cortisone (1) · Extracorporeal Shockwave Therapy (1) · Foot Orthoses (1) · Methylprednisolone Acetate (1) · Microbial Collagenase (1) · Saline Solution (1) · Sodium Chloride (1) · abobotulinumtoxinA (1)
Revance Therapeutics, Inc. (3) · Endo USA Inc., a Keenova Therapeutics Company (1) · Ipsen (1) · Isfahan University of Medical Sciences (1) · King Hamad University Hospital, Bahrain (1) · MiMedx Group, Inc. (1) · National Taiwan University Hospital (1) · University Foot and Ankle Foundation (1) · University of British Columbia (1) · University of Florida (1) · University of South Florida (1) · Western Institute for Veterans Research (1)
United States (9) · Bahrain (1) · Canada (1) · Germany (1) · Iran (1)
Aamina M Khan (1) · Ahsan J Butt (1) · Babak Baravarian, DPM (1) · Farnaz Dehghan, MD (1) · Jack Taunton, Dr. (1) · Mikol Anderson, DPM (1) · Stuart D Miller, MD (1)
PMID 11991474, PMID 16556754, PMID 21255460, PMID 22349369, PMID 22673486
2004 (1), R01AG071646 (1)